Gastrointestinal Cancer

Gastric and intestinal cancers interfere with the body’s ability to digest and absorb nutrients. Gastric, or stomach, cancers are frequently associated with Helicobacter pylori infections and smoking. The chronic inflammation caused by these mediators may contribute significantly to the pathogenesis of gastric cancer. In colon cancer, polyps (benign aggregates of cells) protrude into the lumen of the colon. These polyps may eventually become cancerous and spread throughout the body. ATCC’s collection of cells has been used in the development of a number of biomarker and personalized assays.

Stomach Cancer Cell Panel

The ATCC Stomach Cancer Cell Line Panel is composed of six cell lines that may be used to enhance your biological understanding of top genetic alterations across tumor types, as well as for chemotherapeutic assay development.

Stomach Cancer Cell Panel

Cells of the Digestive System

ATCC's vast collection of stomach, esophagus, small intestine, and colon cells includes those derived from normal and diseased tissues of multiple species. ATCC also carries cells derived from the accessory organs of the digestive system, such as the liver and the pancreas.

Esophageal Cell Lines

Small Intestine Cell Lines

Colon Cell Lines

Hepatic Cell Lines

Pancreatic Cell Lines

Colon Cancer Tumor Cell Panels

Mutations in BRAF and KRAS are important predictors of patient response to chemotherapy. ATCC has developed two colon cancer panels with varying degrees of genetic complexity, organized by BRAF or KRAS mutations. 

Colon Cancer Cell Panels